Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Malignant Lymphoma

Free Subscription Articles published in J Natl Cancer Inst Retrieve available abstracts of 26 articles: HTML format

Single Articles

October 2026
1. WADHWA A, Dai C, Ahmed O, Kessel S, et al
   Changes In body composition and subsequent risk of relapse In childhood hodgkin lymphoma.
   J Natl Cancer Inst. 2026 Oct 13:djag391. doi: 10.1093.
   PubMed     Abstract available
   
   
   
2. ROGERS JR, Ward ZJ, Feraco AM, Castellino SM, et al
   Immunotherapy-Based Therapies in Pediatric Hodgkin Lymphoma: Potential to Narrow the Gap in Long-Term Survival.
   J Natl Cancer Inst. 2026 Oct 1:djag353. doi: 10.1093.
   PubMed     Abstract available
   
   
   September 2026
3. RAVINDRAN M, Peng J, Zipursky J, Luo J, et al
   Evaluating the incidence and predictors of chronic opioid use in early survivorship for patients with diffuse large B-cell lymphoma.
   J Natl Cancer Inst. 2026 Sep 1:djag305. doi: 10.1093.
   PubMed     Abstract available
   
   
   June 2026
4. ROGERS JR, Ward ZJ, Stratton KL, Leisenring WM, et al
   Modeling long-term mortality and morbidity in pediatric Hodgkin lymphoma survivors after reduced radiotherapy exposure.
   J Natl Cancer Inst. 2026 Jun 12:djag186. doi: 10.1093.
   PubMed     Abstract available
   
   
   
5. MAO G, Lan H
   Re: Cardiovascular disease risk after radiotherapy and anthracycline-based chemotherapy for diffuse large B-cell lymphoma.
   J Natl Cancer Inst. 2026 Jun 3:djag165. doi: 10.1093.
   PubMed    
   
   
   May 2026
6. DOLATKHAH R, Onyije FM, Bouaoun L, Olsson A, et al
   Early life environmental exposures and birth characteristics and childhood lymphoma risk: a systematic review and meta-analysis.
   J Natl Cancer Inst. 2026 May 7:djag136. doi: 10.1093.
   PubMed     Abstract available
   
   
   April 2026
7. LAMMERS EM, Zijlstra JM, Schaapveld M, Haagsma JA, et al
   The impact of survivorship care on burden of disease among Hodgkin lymphoma survivors.
   J Natl Cancer Inst. 2026 Apr 11:djag080. doi: 10.1093.
   PubMed     Abstract available
   
   
   March 2026
8. GEURTS YM, Neppelenbroek SIM, Aleman BMP, Janus CPM, et al
   Cardiovascular disease risk after radiotherapy and anthracycline-based chemotherapy for diffuse large B-cell lymphoma.
   J Natl Cancer Inst. 2026 Mar 25:djag085. doi: 10.1093.
   PubMed     Abstract available
   
   
   
9. ROSHANI S, Boekel NB, Van Leeuwen FE, Rademakers SE, et al
   Predicting long-term absolute risk of lung cancer in Hodgkin lymphoma patients.
   J Natl Cancer Inst. 2026 Mar 23:djag090. doi: 10.1093.
   PubMed     Abstract available
   
   
   January 2026
10. DAKHALLAH N, Steglich J, Gowdy C, Milgrom SA, et al
    Imaging pitfalls in pediatric, adolescent, and young adult hodgkin lymphoma: a SEARCH for CAYAHL initiative to bridge multidisciplinary patient care.
    J Natl Cancer Inst. 2026 Jan 30:djag016. doi: 10.1093.
    PubMed     Abstract available
    
    
    
11. LOWE LS, Kim DK, Rohde CH, Yu JB, et al
    Incidence of breast implant-associated anaplastic large cell lymphoma.
    J Natl Cancer Inst. 2026 Jan 22:djag019. doi: 10.1093.
    PubMed     Abstract available
    
    
    
12. BAILEY JT, Chang CJ, Gaston SA, Jackson CL, et al
    Use of hair straighteners and chemical relaxers and incidence of non-reproductive cancers.
    J Natl Cancer Inst. 2026;118:94-101.
    PubMed     Abstract available
    
    
    December 2025
13. HEMMINGSEN CH, Morch LS, Arvedsen J, Dahl EO, et al
    Hormonal contraception and lymphoma risk in danish women 15-49 years: a nationwide cohort study.
    J Natl Cancer Inst. 2025 Dec 22:djaf371. doi: 10.1093.
    PubMed     Abstract available
    
    
    
14. TAO J, Luo Q, Haas CB, Mbulaiteye SM, et al
    Risk of lymphoma among people with HIV in the United States, 2001-2019.
    J Natl Cancer Inst. 2025;117:2505-2512.
    PubMed     Abstract available
    
    
    October 2025
15. CHOKUNONGA E, Makunike-Mutasa R, Borok M, Chirenje MZ, et al
    Trends in the incidence of cancers related to HIV-AIDS in Harare, Zimbabwe 1990-2019.
    J Natl Cancer Inst. 2025;117:2096-2102.
    PubMed     Abstract available
    
    
    September 2025
16. YAMSHON S, Leonard JP
    Unstacking the deck in follicular lymphoma clinical trials.
    J Natl Cancer Inst. 2025 Sep 12:djaf231. doi: 10.1093.
    PubMed    
    
    
    
17. KELLY RL, Machiela MJ
    Clones and clots in lymphoma transplant survivors.
    J Natl Cancer Inst. 2025 Sep 11:djaf211. doi: 10.1093.
    PubMed    
    
    
    July 2025
18. WILLIAMS AM, Rodday AM, Renfro LA, Wu Y, et al
    Group-based trajectories of health-related quality of life among pediatric patients with high-risk Hodgkin lymphoma.
    J Natl Cancer Inst. 2025 Jul 23:djaf197. doi: 10.1093.
    PubMed     Abstract available
    
    
    
19. WONG KSQ, Martynchyk A, Krisnadi Z, Swain F, et al
    Meeting trial eligibility in follicular lymphoma patients is associated with overall survival but not progression-free survival.
    J Natl Cancer Inst. 2025 Jul 10:djaf174. doi: 10.1093.
    PubMed     Abstract available
    
    
    
20. GANGARAJU R, Chen Y, Hageman L, Bosworth A, et al
    Clonal hematopoiesis and subsequent venous thromboembolism among survivors of autologous transplantation for lymphoma.
    J Natl Cancer Inst. 2025 Jul 2:djaf164. doi: 10.1093.
    PubMed     Abstract available
    
    
    January 2025
21. MEZGER NCS, Seraphin TP, Balle R, Griesel M, et al
    NCCN guideline-concordant cancer care in sub-Saharan Africa: a population-based multicountry study of 5 cancers.
    J Natl Cancer Inst. 2025;117:120-133.
    PubMed     Abstract available
    
    
    November 2024
22. ROBERTI S, van Leeuwen FE, Diallo I, de Vathaire F, et al
    Prediction of breast cancer risk for adolescents and young adults with Hodgkin lymphoma.
    J Natl Cancer Inst. 2024 Nov 1:djae274. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2024
23. SCHAFER ES, Rushing T, Crews KR, Annesley C, et al
    Optimizing early phase clinical trial washout periods: a report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium.
    J Natl Cancer Inst. 2024 Jul 4:djae165. doi: 10.1093.
    PubMed     Abstract available
    
    
    January 2024
24. WYATT KD, Birz S, Castellino SM, Henderson TO, et al
    Accelerating pediatric hodgkin lymphoma research: the hodgkin lymphoma data collaboration (NODAL).
    J Natl Cancer Inst. 2024 Jan 25:djae013. doi: 10.1093.
    PubMed     Abstract available
    
    
    November 2023
25. SIEGEL DA, King JB, Lupo PJ, Durbin EB, et al
    Counts, incidence rates, and trends of pediatric cancer in the United States, 2003-2019.
    J Natl Cancer Inst. 2023;115:1337-1354.
    PubMed     Abstract available
    
    
    September 2023
26. 
    Correction to: Mortality among patients with diffuse large B-cell lymphoma and mental disorders: a population-based study.
    J Natl Cancer Inst. 2023 Sep 22:djad199. doi: 10.1093.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum